A dermatology review flagged that there are essentially no adequate studies of intravenous glutathione for skin lightening, and that its safety for repeated IV use has not been established (a dermatology review concluding that IV glutathione for skin lightening has inadequate safety data)
Traditionally, diabetes care relied on a mix of therapeutic classes including insulins, SGLT2 inhibitors, and biguanides such as metformin
In medicine, a slightly less potent treatment that a person is willing and able to take consistently can sometimes be more useful in the real world than a theoretically stronger treatment they never start or quickly stop
The company holds a 4.1 out of 5.0 rating on Trustpilot with over 2,000 reviews
The area under the curve (AUC) is shaded
Genentech Headquarters: South San Francisco, California, USA Number of employees: 13,500 Year founded: 1976 Revenue (2025): $14.2 billion Forbes overall rank: 127 As a wholly-owned member of Roche Holding AG, Genentech contributed to the groups robust 2025 performance